Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

• Váldodahkkit: M Cristina Pimenta (Dahkki), Thiago Silva Torres (Dahkki), Brenda Hoagland (Dahkki), Mirian Cohen (Dahkki), Claudio Gruber Mann (Dahkki), Cristina M Jalil (Dahkki), Eduardo Carvalheira (Dahkki), Lucilene Freitas (Dahkki), Nilo Fernandes (Dahkki), Debora Castanheira (Dahkki), Marcos Benedetti (Dahkki), Julio Moreira (Dahkki), Keila Simpson (Dahkki), Roberta Trefiglio (Dahkki), Gabrielle O'Malley (Dahkki), Valdilea G Veloso (Dahkki), Beatriz Grinsztejn (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: JMIR Publications, 2024-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

BackgroundAlthough long-acting, injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) has proven efficacious for HIV prevention in clinical trials, research is needed to guide effective implementation in real-world settings. Formative work with community members and health care providers...